Question Bank › Staircase quarter: best recent period just repor

Staircase quarter: best recent period just reported, and the next step up is already in hand

Calls Tested
457
Answered YES
4
Hit Rate
0.9%
rare by design

Supernus Pharmaceuticals, Inc. (SUPN) — this company's answers

NO on the Q3 2016 call 2016-11-18 D
The model's full reasoning — Q3 2016 call → NO我们根据提供的财报电话会议记录来判断。管理层是否将刚报告的时期描述为近期最强的业务阶段,并且同时表示接下来的时期会更大,且基于已掌握的事物。 分析: - 关于近期业绩:管理层提到“Strong growth in product prescriptions and net product sales”,并给出具体数字,如净产品销售额同比增长48%,处方量增长30%等。但这是否是“最强”或“高水位”?管理层没有明确说这是“最强”或“记录”,只是说“强劲增长”。没有明确说这是近期最好的时期。 - 关于未来:管理层没有明确说下一季度会更大。他们调整了全年净产品销售额指引,从2亿-2.1亿提高到2.05亿-2.1亿,但这是全年,不是下一季度。对于下一季度,没有明确说会超过本季度。此外,他们提到R&D费用会上升,但那是费用。没有提到下一季度业务会更大。 - 管理层提到“we will be ready to launch the migraine indication soon after receiving full FDA approval”,但这是未来事件,不是已掌握的事物。 - 关于SPN-812,有积极数据,但那是管线,不是当前业务。 因此,管理层没有明确将本季度描述为“最强”或“高水位”,也没有明确说下一季度会更大。他们只是说增长强劲,但未与自身历史比较。所以答案应为NO。

← Back to the full SUPN analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management present the just-reported period as one of the STRONGEST STRETCHES OF BUSINESS THE COMPANY HAS HAD IN ITS RECENT HISTORY — and, in the same breath, tell investors that the PERIOD DIRECTLY AHEAD IS SET TO BE BIGGER STILL, grounding that near-term step-up in things the company ALREADY HAS IN HAND rather than in hopes about the market? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent staircase pattern with BOTH halves present: (1) THE PERIOD JUST FINISHED WAS A HIGH POINT, IN MANAGEMENT'S OWN TELLING. Management characterizes the recent period's business — its orders, volumes, customers, activity, output, wins, or overall performance — as among the strongest the company has recently produced: a record or near-record stretch, a clear high-water mark versus the company's own recent past, or plainly described as the best the business has been running in a long while. The strength must be about real activity that already happened, in whatever terms fit the industry, and must be management's own framing rather than a number an analyst characterizes as strong. (2) THE VERY NEXT STRETCH IS DESCRIBED AS BIGGER, FOR REASONS ALREADY IN HAND. Management indicates that the period immediately ahead — the coming quarter, season, or comparable near-term stretch — is expected to step ABOVE the high point just reported, and supports that expectation with things that already exist or are already committed: orders or bookings already received, work already sold or scheduled, customers already ramping, capacity or product already coming online, commitments already signed, or activity already running at a higher pace than the reported period's average. The essence is that the next step of the staircase is already under the company's feet — management can point to it — rather than something that requires demand to improve, markets to recover, or new business to be won first. Answer NO if the reported period is weak, mixed, merely in-line, or only recovering toward past levels, with no recent high point in management's own framing. NO if management describes the strong period as a peak, one-time bulge, pull-forward, or level it expects to come back down from. NO if the next period is guided flat, down, or merely 'continued strong' without a described step above the level just reported. NO if the expected step-up rests mainly on hoped-for demand, seasonality alone, market recovery, pipeline conversion, or deals not yet closed rather than on business or capability already in hand. NO if either half appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ADSK Autodesk, Inc. Q3 2019 2018-11-20 A
UPLD Upland Software, Inc. Q4 2017 2018-03-08 C+
GPOR Gulfport Energy Corporation Q4 2016 2017-02-14 A
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C

How the model reasoned

GPOR · Q4 2016 → YESThe question is: Does management present the just-reported period as one of the strongest stretches of business the company has had in its recent history — and, in the same breath, tell investors that...YES The transcript shows management framing 2016 as a defining year with record production growth (32% YoY) and reserves increases, calling it a high point in their own words ("another year of record production growth"). For 2017, they announce a $1B–$1.1B capital budget 45–53% higher production growth, grounded in the SCOOP acquisition (already closed or closing), doubled Utica rig count, and existing acreage/hedges—not market hopes. They also note Q1 2017 activity ramping to four net wells turned-to-sales.
UPLD · Q4 2017 → YESThe question is: Does management present the just-reported period as one of the STRONGEST STRETCHES OF BUSINESS THE COMPANY HAS HAD IN ITS RECENT HISTORY — and, in the same breath, tell investors that...YES Management frames Q4 as an "incredibly strong close" with a "record 44% revenue growth" and 1,300-basis-point EBITDA margin expansion to 35%, calling it the 14th consecutive quarter of beating guidance and part of an "outstanding year.
HPP · Q4 2015 → YESThe question is: Does management present the just-reported period as one of the strongest stretches of business the company has had in its recent history — and, in the same breath, tell investors that...YES Victor Coleman explicitly frames 2015 as a “banner year” and “landmark year” with “strong fourth quarter earnings,” “all-time high” demand in Q4, and “impressive” results that “rounded out” the year.

More from the question bank

Selling the shovels to a customer who just gCheap-to-serve incremental businessConviction backed by things in handQ&A has flipped from problems to possibilitiRoom to raise the ceilingBreak from their own historyAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.